Differences in cancer patients' and clinicians' preferences for disclosure of uncertain genomic tumor testing results

摘要

Objective: To compare clinicians' and patients' preferences for disclosure of genomic tumor testing (GTT) results; to determine the sensitivity of these disclosure preferences to uncertainty about the actionability of results; and to explore factors associated with disclosure preferences.